Creatinine Test Device Market, Global Outlook and Forecast 2024-2031

Report ID: 1211221 | Published Date: Jan 2025 | No. of Page: 79 | Base Year: 2024 | Rating: 4.5 | Webstory: Check our Web story

Since creatinine is usually measured by various biochemical analyzers using special kits, this market is difficult to count. Therefore, this report only counts POC (point of care) devices.
This report contains market size and forecasts of Creatinine Test Device in global, including the following market information:
Global Creatinine Test Device Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Creatinine Test Device Market Sales, 2017-2022, 2023-2028, (K Units)
Global top five Creatinine Test Device companies in 2021 (%)
The global Creatinine Test Device market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Creatinine Blood Test Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Creatinine Test Device include Nova Biomedical, Siemens, Abbott and Radiometer, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Creatinine Test Device manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Creatinine Test Device Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Creatinine Test Device Market Segment Percentages, by Type, 2021 (%)
Creatinine Blood Test
Creatinine Urine Test
Global Creatinine Test Device Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Creatinine Test Device Market Segment Percentages, by Application, 2021 (%)
Hospitals
Clinics
Others
Global Creatinine Test Device Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Creatinine Test Device Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Creatinine Test Device revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Creatinine Test Device revenues share in global market, 2021 (%)
Key companies Creatinine Test Device sales in global market, 2017-2022 (Estimated), (K Units)
Key companies Creatinine Test Device sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Nova Biomedical
Siemens
Abbott
Radiometer

Frequently Asked Questions
Creatinine Test Device Market report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Creatinine Test Device Market report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Creatinine Test Device Market report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports